Company Overview
Abbott Healthcare Products Ltd is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Wednesday 05 March 1969, so this is a well established company. Abbott Healthcare Products Ltd has been in business for 57 years and 1 month. The accounts status is full and the accounts are next due on Wednesday 30 September 2026.
Registered Address

Abbott House Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameABBOTT HEALTHCARE PRODUCTS LTD
Company Number00949253
Registered Office AddressAbbott House Vanwall Business Park
 Vanwall Road
 SL6 4XE
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date05/03/1969
Accounting Reference Date Day31
Accounting Reference Date Month12
Accounts Next Due Date30/09/2026
Accounts Last Made Up Date31/12/2024
Accounts Account CategoryFULL
Returns Next Due Date06/03/2017
Returns Last Made Up Date06/02/2016
Previous Company NameChanged Date
SOLVAY HEALTHCARE LIMITED17 Feb 2010
Directors & Members
Show Resigned
Ross Campbell - Director
(British, 50 years old, born April 1976)
Appointed 25 April 2025
 Active
Michael Clayton - Director
(British, 52 years old, born April 1974)
Appointed 23 March 2020
 Active
James Wenner - Director
(American, 59 years old, born September 1967)
Appointed 10 December 2025
 Active
Secretaries
Show Resigned
Kevan Gogay - Secretary
Appointed 13 February 2015
 Active
Other Company Directorships
Ross Campbell
ABBOTT (UK) FINANCE LIMITED
ABBOTT (UK) HOLDINGS LIMITED
ABBOTT ASIA HOLDINGS LIMITED
ABBOTT ASIA INVESTMENTS LIMITED
ABBOTT AUSTRALASIA HOLDINGS LIMITED
ABBOTT CAPITAL INDIA LIMITED
ABBOTT EQUITY HOLDINGS UNLIMITED
ABBOTT LABORATORIES LIMITED
ABBOTT UK INVESTMENTS LIMITED
ABBOTT UK SUBSIDIARY 2 LIMITED
ABBOTT UK SUBSIDIARY LIMITED
ABBOTT VASCULAR DEVICES (2) LIMITED
ABBOTT VASCULAR DEVICES LIMITED
BRITISH COLLOIDS LIMITED
GYNOCARE LIMITED
KNOLL UK INVESTMENTS UNLIMITED
MUREX BIOTECH LIMITED
Michael Clayton
ABBOTT (UK) FINANCE LIMITED
ABBOTT (UK) HOLDINGS LIMITED
ABBOTT ASIA HOLDINGS LIMITED
ABBOTT ASIA INVESTMENTS LIMITED
ABBOTT AUSTRALASIA HOLDINGS LIMITED
ABBOTT CAPITAL INDIA LIMITED
ABBOTT EQUITY HOLDINGS UNLIMITED
ABBOTT HEALTHCARE CONNECTIONS LIMITED
ABBOTT LABORATORIES LIMITED
ABBOTT UK INVESTMENTS LIMITED
ABBOTT UK SUBSIDIARY 2 LIMITED
ABBOTT UK SUBSIDIARY LIMITED
ABBOTT VASCULAR DEVICES (2) LIMITED
ABBOTT VASCULAR DEVICES LIMITED
BRITISH COLLOIDS LIMITED
FOURNIER PHARMACEUTICALS LIMITED
GYNOCARE LIMITED
KNOLL UK INVESTMENTS UNLIMITED
LINGO TECHNOLOGY UK LIMITED
MANSBRIDGE PHARMACEUTICALS LIMITED
MUREX BIOTECH LIMITED
James Wenner
ABBOTT (UK) FINANCE LIMITED
ABBOTT (UK) HOLDINGS LIMITED
ABBOTT ASIA HOLDINGS LIMITED
ABBOTT ASIA INVESTMENTS LIMITED
ABBOTT AUSTRALASIA HOLDINGS LIMITED
ABBOTT CAPITAL INDIA LIMITED
ABBOTT DIABETES CARE LIMITED
ABBOTT EQUITY HOLDINGS UNLIMITED
ABBOTT MEDICAL U.K. LIMITED
ABBOTT UK INVESTMENTS LIMITED
ABBOTT UK SUBSIDIARY 2 LIMITED
ABBOTT UK SUBSIDIARY LIMITED
ABBOTT VASCULAR DEVICES (2) LIMITED
ABBOTT VASCULAR DEVICES LIMITED
BRITISH COLLOIDS LIMITED
KNOLL UK INVESTMENTS UNLIMITED
MUREX BIOTECH LIMITED
Balance Sheet Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2012 31-Dec-2011
Balance Sheet
Fixed Assets 13,247,000 13,247,000 13,332,000
Current Assets 27,732,000 27,732,000 27,297,000
Creditors Due Within One Year 13,447,000 13,447,000 15,447,000
Working Cap 14,285,000 14,285,000 11,850,000
Total Assets Less Current Liabilities 27,532,000 27,532,000 25,182,000
Long-term Liabilities 6,526,000 6,526,000 10,371,000
Net Assets 21,006,000 21,006,000 14,811,000
Share Capital & Reserves
Share Cap 10,000,000 10,000,000 10,000,000
Profit & Loss Reserves 11,006,000 11,006,000 4,811,000
Other Reserves 0 0 0
Shareholders Funds 21,006,000 21,006,000 14,811,000
Common Size Financial Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2012 31-Dec-2011
Tangible Fixed Assets - - -
Fixed Assets 32.3% 32.3% 32.8%
Stocks Inventory 11.7% 11.7% 12.3%
Debtors 40.8% 40.8% 44.2%
Cash Bank In Hand 15.0% 15.0% 1.1%
Current Assets 67.7% 67.7% 67.2%
Creditors Due Within One Year 32.8% 32.8% 38.0%
Net Current Assets Liabilities 34.9% 34.9% 29.2%
Creditors Due After One Year 15.9% 15.9% 25.2%
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability 51.3% 51.3% 36.5%
Called Up Share Capital 24.4% 24.4% 24.6%
Share Capital Allotted Called Up Paid 24.4% 24.4% 24.6%
Profit Loss Account Reserve 26.9% 26.9% 11.8%
Shareholder Funds 51.3% 51.3% 36.5%
Capital Employed - - -
Total Assets Less Current Liabilities 67.2% 67.2% 62.0%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2012 31-Dec-2011
Liquidity Ratio 2.1 2.1 1.8
Solvency Ratio 2.1 2.1 1.6
Reserves to Assets 0.3 0.3 0.1
Secured Creditors Unlock full report
Mortgages Charges 0
Mortgages Outstanding 0
Mortgages Part Satisfied 0
Mortgages Satisfied 0
Assets and Debt Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2012 31-Dec-2011
Assets 40,979,000 40,979,000 40,629,000
Debt 19,973,000 19,973,000 25,818,000
Net Assets/Debt 21,006,000 21,006,000 14,811,000

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves appeared positive. We would normally view a company positively for this. The balance sheet indicates the net assets of a good sized company. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves appeared positive. We would normally view a company positively for this. The balance sheet indicates the net assets of a good sized company. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves appeared positive. We would normally view a company positively for this. The balance sheet indicates the net assets of a good sized company. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around SL6 4XE
ABBOTT LABORATORIES TRUSTEE COMPANY LIMITED
ABBOTT HOUSE VANWALL BUSINESS PARK, VANWALL ROAD, MAIDENHEAD, BERKSHIRE, SL6 4XE
ABBOTT LABORATORIES LIMITED
ABBOTT HOUSE VANWALL BUSINESS PARK, VANWALL ROAD, MAIDENHEAD, BERKSHIRE, SL6 4XE
BRITISH COLLOIDS LIMITED
ABBOTT HOUSE VANWALL BUSINESS PARK, VANWALL ROAD, MAIDENHEAD, BERKSHIRE, SL6 4XE
ABBOTT (UK) FINANCE LIMITED
ABBOTT HOUSE VANWALL BUSINESS PARK, VANWALL ROAD, MAIDENHEAD, BERKSHIRE, SL6 4XE
MUREX BIOTECH LIMITED
ABBOTT HOUSE VANWALL BUSINESS PARK, VANWALL ROAD, MAIDENHEAD, BERKSHIRE, SL6 4XE
MANSBRIDGE PHARMACEUTICALS LIMITED
Abbott House Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE
ABBOTT VASCULAR DEVICES LIMITED
ABBOTT HOUSE VANWALL BUSINESS PARK, VANWALL ROAD, MAIDENHEAD, BERKSHIRE, SL6 4XE
ABBOTT ASIA INVESTMENTS LIMITED
ABBOTT HOUSE VANWALL BUSINESS PARK, VANWALL ROAD, MAIDENHEAD, BERKSHIRE, SL6 4XE
GYNOCARE LIMITED
C/O ABBOTT UK ABBOTT HOUSE, VANWALL BUSINESS PARK, VANWALL ROAD, MAIDENHEAD, BERKSHIRE, SL6 4XE
ABBOTT IBERIAN INVESTMENTS LIMITED
Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE
Document Filings
Appointment of Mr James Wenner as a director on 10 December 2025
Termination of appointment of Alison Elizabeth Davies as a director on 10 December 2025
Confirmation statement made on 16 November 2025 with no updates
Appointment of Mr Ross Iain Campbell as a director on 25 April 2025
Termination of appointment of Neil Harris as a director on 25 April 2025
Confirmation statement made on 16 November 2024 with no updates
Confirmation statement made on 20 March 2024 with no updates
Appointment of Mrs Alison Elizabeth Davies as a director on 15 October 2023
Termination of appointment of John Arthur Mccoy Jr as a director on 15 October 2023
Confirmation statement made on 20 March 2023 with no updates
Appointment of John Arthur Mccoy Jr as a director on 19 September 2022
Termination of appointment of Karen Ann Krammer as a director on 19 September 2022
Confirmation statement made on 20 March 2022 with no updates
Confirmation statement made on 20 March 2021 with no updates
Appointment of Mr Michael Robert Kendall Clayton as a director on 23 March 2020
Termination of appointment of Georgios Mountrichas as a director on 23 March 2020
Appointment of Mrs Karen Ann Krammer as a director on 1 March 2020
Termination of appointment of Brian Yoor as a director on 29 February 2020
Confirmation statement made on 20 March 2020 with no updates
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free